EUVIMEDEUVIMED entdecken
Multizentrische Studie

Mechanical circulatory support in patients with congenital heart disease: a European Registry for Patients with Mechanical Circulatory Support (EUROMACS) study

Maddalena Ardissino iD, Alec P Morley, Clive Lewis, Catriona Bhagra, Victoria Stoll, Evegnij Popatov, Felix Schoenrath iD, Jan Gummert iD, Piotr Przybyłowski, Joanna Śliwka, Bart Meyns iD, Theo M M H de By und 2 weitere

European Journal of Cardio-Thoracic Surgery · 2024

DOI: 10.1093/ejcts/ezae209 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Cardio-Thoracic Surgery, 2024. Verfasst von Maddalena Ardissino und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care, Royal Papworth Hospital, Royal Papworth Hospital NHS Trust, Cambridge, UK. Hauptthemen laut MEDLINE: Heart Defects, Congenital, Registries, Heart-Assist Devices. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 16 Literaturangaben. Gefördert von: National Institute for Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES This study aims to explore characteristics and clinical outcomes of patients with congenital heart disease (CHD) in the European Registry for Patients with Mechanical Circulatory Support (EUROMACS). METHODS This is a retrospective study of EUROMACS participants receiving MCS as bridge-to-transplant, possible bridge-to-transplant, or rescue therapy/bridge-to-recovery from 2011 to 2023 (n = 5340). Adult and paediatric cohorts were analysed separately. The primary outcome was mortality on MCS; secondary outcomes included recovery, transplant and complications including bleeding, cerebrovascular events, and sepsis. RESULTS Among adult patients, mortality at 1-year was 33.3% among the CHD cohort vs 22.1% in the non-CHD cohort. Adult CHD patients had higher hazards of mortality within the first year after MCS implantation [hazard ratios 1.98, 95% confidence interval (CI) 1.35–2.91, P < 0.001] and bleeding events (subdistribution hazard ratios 2.10, 95% CI 1.40–3.16, P < 0.001) compared with non-CHD patients. Both associations remained significant after accounting for multiple mediators. Among paediatric patients, mortality at 1 year was 22.1% in the CHD cohort vs 17.3% in the non-CHD cohort (hazard ratios 1.39, 95% CI 0.83–2.32, P = 0.213). CONCLUSIONS Adult and paediatric patients with CHD on MCS have higher adverse event risk compared with non-CHD MCS patients, though children did not have greater risk of mortality. As the number of CHD patients requiring advanced heart failure management continues to grow, these findings can enhance informed decision-making. Clinical trial registration number Registry name: EUROMACS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart Defects, CongenitalRegistriesHeart-Assist DevicesHumansMaleFemaleRetrospective StudiesAdultEuropeChildAdolescentChild, PreschoolInfantHeart TransplantationYoung AdultMiddle Aged

Stichwörter der Autor:innen

CongenitalEuropean Registry for Patients with Mechanical Circulatory SupportMechanical circulatory supportOutcomesPaediatricVentricular assist devices

Autor:innen und Institutionen

  • Department of Critical Care, Royal Papworth Hospital, Royal Papworth Hospital NHS Trust, Cambridge, UK.
  • British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • National Heart and Lung Research Institute, Imperial College London, London, UK.
  • Medical Research Council Laboratory of Medical Sciences, Imperial College London, London, UK.
  • Department of Cardiology, Royal Papworth Hospital, Royal Papworth Hospital NHS Trust, Cambridge, UK.
  • Department of Medicine, School of Clinical Medicine, University of Cambridge, Cambridge, UK.

ORCID-Profile: Maddalena Ardissino, Felix Schoenrath, Jan Gummert, Bart Meyns, Nicola Jones, Steven Tsui

Förderung

  • National Institute for Health Research

Zitieren

APA

Ardissino, M., Morley, A. P., Lewis, C., Bhagra, C., Stoll, V., Popatov, E., Schoenrath, F., Gummert, J., Przybyłowski, P., Śliwka, J., Meyns, B., de By, T. M. M. H., Jones, N., & Tsui, S. (2024). Mechanical circulatory support in patients with congenital heart disease: a European Registry for Patients with Mechanical Circulatory Support (EUROMACS) study. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezae209

Vancouver

Ardissino M, Morley AP, Lewis C, Bhagra C, Stoll V, Popatov E, et al. Mechanical circulatory support in patients with congenital heart disease: a European Registry for Patients with Mechanical Circulatory Support (EUROMACS) study. European Journal of Cardio-Thoracic Surgery. 2024. doi:10.1093/ejcts/ezae209

BibTeX
@article{Ardissino2024,
  author = {Ardissino, Maddalena and Morley, Alec P and Lewis, Clive and Bhagra, Catriona and Stoll, Victoria and Popatov, Evegnij and Schoenrath, Felix and Gummert, Jan and Przybyłowski, Piotr and Śliwka, Joanna and Meyns, Bart and de By, Theo M M H and Jones, Nicola and Tsui, Steven},
  title = {Mechanical circulatory support in patients with congenital heart disease: a European Registry for Patients with Mechanical Circulatory Support (EUROMACS) study},
  journal = {European Journal of Cardio-Thoracic Surgery},
  year = {2024},
  doi = {10.1093/ejcts/ezae209}
}
Kostenlos starten →